Andrew I Koven - Net Worth and Insider Trading
Andrew I Koven Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew I Koven owns 3 companies in total, including Kala Bio Inc () , Old API Wind-down Ltd () , and NeuroBo Pharmaceuticals Inc () .
Click here to see the complete history of Andrew I Koven’s form 4 insider trades.
Insider Ownership Summary of Andrew I Koven
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Kala Bio Inc | 2019-06-05 | director | |
Old API Wind-down Ltd | 2018-06-04 | President & Chief Business Off | |
NeuroBo Pharmaceuticals Inc | 2022-06-09 | director |
Andrew I Koven Trading Performance
Andrew I Koven Ownership Network
Ownership Network List of Andrew I Koven
Ownership Network Relation of Andrew I Koven
Andrew I Koven Owned Company Details
What does Kala Bio Inc do?
Who are the key executives at Kala Bio Inc?
Andrew I Koven is the director of Kala Bio Inc. Other key executives at Kala Bio Inc include CHIEF BUSINESS OFFICER Darius Kharabi , director & Chief Executive Officer Mark T Iwicki , and Chief Financial Officer Mary Reumuth .
Kala Bio Inc () Insider Trades Summary
Over the past 18 months, Andrew I Koven made no insider transaction in Kala Bio Inc (). Other recent insider transactions involving Kala Bio Inc () include a net sale of 5,298 shares made by Mark T Iwicki , a net sale of 1,951 shares made by Romulus K Brazzell , and a net sale of 1,681 shares made by Todd Bazemore .
In summary, during the past 3 months, insiders sold 0 shares of Kala Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,277 shares of Kala Bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,277 shares.
Kala Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Kala Bio Inc Insider Transactions
Andrew I Koven Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew I Koven. You might contact Andrew I Koven via mailing address: 3 Columbus Circle, Suite 1710, C/o Aralez Pharmaceuticals Inc., New York Ny 10019.